Catalyst Wire Dossier Catalyst Wire Dossier

MK-0974

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0974, covering 2014-08-29 to 2014-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031) [Phase 3]

See pricing